title: Infectious diseases. Drug developers finally take aim at a neglected disease.
authors.forename: Mitch
authors.initials: M
authors.lastname: Leslie
mesh_terms: D014355:Chagas Disease / Q000188:drug therapy* / Q000453:epidemiology; D017277:Drug Approval; D055808:Drug Discovery; D004353:Drug Evaluation, Preclinical; D058492:Drug Repositioning; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D057166:High-Throughput Screening Assays; D006801:Humans; D058069:Neglected Diseases / Q000188:drug therapy*; D014344:Trypanocidal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D014349:Trypanosoma cruzi / Q000187:drug effects / Q000201:enzymology
chemical_list: D004791:Enzyme Inhibitors; D014344:Trypanocidal Agents